Physician profile
Ceren Karaali
NPI 1518604297
$1,032.32
in general payments reported to CMS, 2019-2025
11 companies · $1,032 in 2025
The $1,032 reported for 2025 was more than what 88% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $1,032.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $832 · Education: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $832.38 |
| Education | $199.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exelixis INC. | $219.65 | 2025 | Cabometyx |
| Genzyme Corporation | $152.27 | 2025 | |
| Jazz Pharmaceuticals INC. | $132.30 | 2025 | |
| Daiichi Sankyo INC. | $107.98 | 2025 | Datroway |
| Pharmaessentia USA Corporation | $107.10 | 2025 | Besremi |
| Regeneron Healthcare Solutions, INC. | $100.00 | 2025 | Lynozyfic |
| Alexion Pharmaceuticals, INC. | $99.99 | 2025 | Soliris |
| Sobi, INC | $34.20 | 2025 | |
| Geron Corporation | $30.06 | 2025 | Rytelo |
| Astellas Pharma US INC | $24.96 | 2025 | Padcev |
| Syndax Pharmaceuticals, INC. | $23.81 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ceren Karaali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.